Literature DB >> 26978875

ICE SYNDROME--CASE REPORT.

Valeria Coviltir, Dinu Valentin.   

Abstract

Iridocorneal endothelial (ICE) syndrome encompasses a group of rare ocular pathologies with unilateral involvement, frequently affecting young women. The disease complex includes essential iris atrophy, Chandler's syndrome, and Cogan-Reese syndrome. In the following article, we present a case of Iridocorneal endothelial syndrome in which a late diagnosis was made and who underwent surgery for advanced glaucoma.

Entities:  

Mesh:

Year:  2015        PMID: 26978875      PMCID: PMC5712930     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  7 in total

1.  The histopathology of the iridocorneal-endothelial syndrome.

Authors:  S G Levy; C M Kirkness; J Moss; L Ficker; A C McCartney
Journal:  Cornea       Date:  1996-01       Impact factor: 2.651

2.  Endothelialization of filtering bleb in iris nevus syndrome.

Authors:  M Yanoff; H G Scheie; M I Allman
Journal:  Arch Ophthalmol       Date:  1976-11

3.  Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome.

Authors:  J A Alvarado; J L Underwood; W R Green; S Wu; C G Murphy; D G Hwang; T E Moore; D O'Day
Journal:  Arch Ophthalmol       Date:  1994-12

4.  The essential iris atrophies.

Authors:  M B Shields; D G Campbell; R J Simmons
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

5.  Specular microscopy of iridocorneal endothelia syndrome.

Authors:  L W Hirst; H A Quigley; W J Stark; M B Shields
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

6.  Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.

Authors:  Bryan K Hong; Brian A Francis
Journal:  Digit J Ophthalmol       Date:  2013-05-01

7.  Corneal endothelial cell density and morphology in normal Iranian eyes.

Authors:  Mohammad Nasser Hashemian; Sasan Moghimi; Masood Aghsaie Fard; Mohammad Reza Fallah; Mohammad Reza Mansouri
Journal:  BMC Ophthalmol       Date:  2006-03-06       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.